Grants and Contributions:
Title:
SAVIOR™ product design, development, and prototyping
Agreement Number:
939496
Agreement Value:
$150,000.00
Agreement Date:
Nov 14, 2019 - Mar 31, 2021
Description:
The objective of the proposed project is to further develop medication delivery system of SAVIOR™ medical device into a prototype model ready for testing, from TR3 to TRL6. The next step of development is to bench test the device components and then combine them into a complete prototype with several iterations of improvement and refinement. Ultimate goal is to advance development of SAVIOR™ for safe, quick and simple auto injection of medication Tranexamic Acid (TXA) in field settings to save lives of people suffering from massive trauma including bleeding.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Edmonton, Alberta, CA T6R 0M5
Reference Number:
172-2019-2020-Q3-939496
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
701428310
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 10,000 dollars.
Amendment Date
Mar 22, 2021
Recipient's Legal Name:
MACH32 INC.
Federal Riding Name:
Edmonton Riverbend
Federal Riding Number:
48018
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: